Delalys progression to type 2 diabetes in people in impaired glucose tolerance
Promote weight loss in patient with obesity with non insulin dependent DM.
An insulin sensitising agent, lowering fasting plasma insulin concentrations by inducing greater peripheral uptake of glucose, as well as decreasing hepatic glucose output